• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Basic Materials·ITX.L
Share

Itaconix plc Stocks

£ 182Last Updated 16.10.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

£ 32.72M

£ 182
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Itaconix plc, alongside its affiliated entities, specializes in the creation, production, and distribution of bio-based polymers. These innovative materials serve the personal care, household product, and industrial sectors throughout North America and Europe. For home and industrial applications, its offerings encompass water-soluble polymers like Itaconix TSI, Itaconix DSP, Itaconix CHT, and Itaconix VELASOFT, as well as water-soluble odor neutralizers such as Itaconix ZINADOR 22L and 35L. In the personal care market, Itaconix supplies water-soluble fixating complexes, specifically Itaconix VELAFRESH ZP20 and ZP30, along with Nouryon Amaze SP, an ingredient for hair styling. Established in 2012, the company operated as Revolymer plc before adopting its current name, Itaconix plc, in February 2017. The firm's main office is located in Stratham, New Hampshire.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is overvalued on EV/EBITDA.

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Very favourable
7/7
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

19.10.2026 20:13

Silence Therapeutics soars 125% as Merck to acquire developer of blood cancer drug

19.10.2026 18:43

"A buying opportunity is emerging": Nasdaq jumped 1% after the sell-off

19.10.2026 18:30

Analysts see 35% upside in label maker Brady on data center demand and Honeywell deal

19.10.2026 18:09

Goldman names 23 'unloved' defensive stocks as tech falters

19.10.2026 16:08

Morning in New York: Looking for a Foothold Ahead of Tech Giants' Earnings Reports

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026